Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.7 |
mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.023 | 0.7 |
mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |